Omeprazole and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data
Paranasal sinus hypersecretion is found among people who take Omeprazole, especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years.
The phase IV clinical study analyzes which people take Omeprazole and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 351,142 people who have side effects when taking Omeprazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
351,142 people reported to have side effects when taking Omeprazole.
Among them, 129 people (0.04%) have Paranasal sinus hypersecretion.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 330,224 Omeprazole users for its effectiveness, alternative drugs and more.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 661 drugs and 378 conditions by eHealthMe.
Number of Omeprazole and Paranasal sinus hypersecretion reports submitted per year:
Time on Omeprazole when people have Paranasal sinus hypersecretion *:
Gender of people who have Paranasal sinus hypersecretion when taking Omeprazole*:
Age of people who have Paranasal sinus hypersecretion when taking Omeprazole *:
Common drugs people take besides Omeprazole *:
Common side effects people have besides Paranasal sinus hypersecretion *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Paranasal sinus hypersecretion and when was it recovered:
Expand to all the drugs that have ingredients of omeprazole:
Alternative drugs to, pros and cons of Omeprazole:
- Omeprazole (330,224 reports)
Common Omeprazole side effects:
Browse all side effects of Omeprazole:a b c d e f g h i j k l m n o p q r s t u v w x y z
Paranasal sinus hypersecretion treatments and more:
- Paranasal sinus hypersecretion (4,043 reports)
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (661 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (378 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Edurant and Prezcobix drug interaction - 5 seconds ago
- Temaz and Feelings Of Worthlessness - 8 seconds ago
- Kalbitor and Tooth Extraction - 11 seconds ago
- Pain and Endometrial Hyperplasia - 14 seconds ago
- Videx Ec and Abdominal Pain - 21 seconds ago
- Birth Control and Joint Contracture - 27 seconds ago
- Sandostatin and Injection Site Pruritus - 27 seconds ago
- Folic Acid and Injection Site Urticaria - 29 seconds ago
- Tricor and Tooth Loss - 30 seconds ago
- Strattera and Blood Urea Increased - 30 seconds ago